MX9706053A - Comprimido de maleato de trimebutina con recubrimiento laminar. - Google Patents

Comprimido de maleato de trimebutina con recubrimiento laminar.

Info

Publication number
MX9706053A
MX9706053A MX9706053A MX9706053A MX9706053A MX 9706053 A MX9706053 A MX 9706053A MX 9706053 A MX9706053 A MX 9706053A MX 9706053 A MX9706053 A MX 9706053A MX 9706053 A MX9706053 A MX 9706053A
Authority
MX
Mexico
Prior art keywords
trimebutine maleate
laminar covering
nucleus
maleate tablet
liberation
Prior art date
Application number
MX9706053A
Other languages
English (en)
Other versions
MXPA97006053A (es
Inventor
Loutfy Benkerrour
Bernard Doat
Original Assignee
Jouveinal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9706053(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jouveinal Lab filed Critical Jouveinal Lab
Publication of MXPA97006053A publication Critical patent/MXPA97006053A/es
Publication of MX9706053A publication Critical patent/MX9706053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Abstract

Comprimido dotado de recubrimiento laminar de maleato de trimebutina destinado a la administracion por vía oral, caracterizado por comprender: un nucleo que comprende de 30 a 60% de maleato de trimebutina, y excipientes adaptados a la preparacion de dicho nucleo siendo éstos apropiados a la estabilidad y a la liberacion del principio activo. Un recubrimiento laminar hidrosoluble, de eficacia transitoria pero suficiente para preservar de la desintegracion al nucleo y de la liberacion prematura del principio activo en el medio bucal.
MX9706053A 1996-08-07 1997-08-07 Comprimido de maleato de trimebutina con recubrimiento laminar. MX9706053A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609956 1996-08-07
FR9609956A FR2752162B1 (fr) 1996-08-07 1996-08-07 Comprime de maleate de trimebutine pellicule

Publications (2)

Publication Number Publication Date
MXPA97006053A MXPA97006053A (es) 1998-02-01
MX9706053A true MX9706053A (es) 1998-02-28

Family

ID=9494890

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA98010007A MXPA98010007A (es) 1996-08-07 1997-07-11 Comprimido de maleato de trimebutian en forma de pelicula.
MX9706053A MX9706053A (es) 1996-08-07 1997-08-07 Comprimido de maleato de trimebutina con recubrimiento laminar.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA98010007A MXPA98010007A (es) 1996-08-07 1997-07-11 Comprimido de maleato de trimebutian en forma de pelicula.

Country Status (27)

Country Link
EP (1) EP0942718B1 (es)
JP (1) JP2000515535A (es)
KR (1) KR100539642B1 (es)
CN (1) CN1206986C (es)
AR (1) AR008820A1 (es)
AT (1) ATE300297T1 (es)
AU (1) AU3697097A (es)
BR (1) BR9711032B1 (es)
CA (1) CA2256751C (es)
CO (1) CO4900042A1 (es)
CZ (1) CZ294195B6 (es)
DZ (1) DZ2272A1 (es)
EA (1) EA001506B1 (es)
ES (2) ES2244002T3 (es)
FR (1) FR2752162B1 (es)
GR (1) GR1002907B (es)
HK (1) HK1020888A1 (es)
HU (1) HU228040B1 (es)
IT (1) IT1294671B1 (es)
MX (2) MXPA98010007A (es)
OA (1) OA10968A (es)
PL (1) PL188839B1 (es)
PT (2) PT942718E (es)
TN (1) TNSN97134A1 (es)
TR (1) TR199900261T2 (es)
UA (1) UA52682C2 (es)
WO (1) WO1998005320A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
FR2834889B1 (fr) 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
EP1726621A1 (en) * 2005-05-26 2006-11-29 Cytec Surface Specialties, S.A. Thermosetting powder compositions
CN100393311C (zh) * 2006-01-26 2008-06-11 孙伟丰 马来酸曲美布汀分散片
CN1927185B (zh) * 2006-10-19 2010-05-19 开开援生制药股份有限公司 具速释部分的马来酸曲美布汀缓释片及其制备工艺
BRPI0916689A2 (pt) 2008-07-28 2015-11-17 Takeda Pharmaceutical composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
KR101048487B1 (ko) * 2008-08-19 2011-07-11 한국콜마 주식회사 말레인산트리메부틴 서방정
KR101220829B1 (ko) * 2010-07-16 2013-01-10 안국약품 주식회사 트리메부틴 함유 서방성 정제
CN102462657A (zh) * 2010-11-15 2012-05-23 杭州赛利药物研究所有限公司 马来酸曲美布汀栓剂及其制备方法
WO2014148520A1 (ja) * 2013-03-21 2014-09-25 大正製薬株式会社 固形製剤
RU2536254C1 (ru) * 2013-11-26 2014-12-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки-ретард с тримебутином
CN107205984B (zh) * 2015-01-26 2019-11-12 第一三共株式会社 吡咯甲酰胺的固体组合物
RU2706166C2 (ru) * 2017-11-20 2019-11-14 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770300C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770301C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
CN113171353B (zh) * 2021-04-25 2022-10-21 海南普利制药股份有限公司 一种马来酸曲美布汀片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
FR2640876B1 (es) * 1988-12-28 1993-09-24 Jouveinal Sa
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JP2836493B2 (ja) * 1994-08-04 1998-12-14 田辺製薬株式会社 苦味隠蔽されたマレイン酸トリメブチン含有製剤

Also Published As

Publication number Publication date
EP0942718A1 (fr) 1999-09-22
PL188839B1 (pl) 2005-05-31
ES2244002T3 (es) 2005-12-01
EA199900102A1 (ru) 1999-06-24
PT102031A (pt) 1998-02-27
MXPA98010007A (es) 2002-07-22
AR008820A1 (es) 2000-02-23
CZ37699A3 (cs) 1999-05-12
TNSN97134A1 (fr) 2005-03-15
CN1226162A (zh) 1999-08-18
IT1294671B1 (it) 1999-04-12
ES2130081B1 (es) 2000-01-01
CA2256751A1 (fr) 1998-02-12
HU228040B1 (en) 2012-09-28
BR9711032B1 (pt) 2008-11-18
ATE300297T1 (de) 2005-08-15
PT102031B (pt) 2004-07-30
KR100539642B1 (ko) 2005-12-29
EA001506B1 (ru) 2001-04-23
OA10968A (fr) 2001-10-30
PL331517A1 (en) 1999-07-19
BR9711032A (pt) 1999-08-17
CO4900042A1 (es) 2000-03-27
FR2752162B1 (fr) 1998-11-06
CZ294195B6 (cs) 2004-10-13
UA52682C2 (uk) 2003-01-15
CN1206986C (zh) 2005-06-22
HUP9902878A2 (hu) 2000-04-28
HUP9902878A3 (en) 2000-11-28
PT942718E (pt) 2005-10-31
JP2000515535A (ja) 2000-11-21
HK1020888A1 (en) 2000-05-26
WO1998005320A1 (fr) 1998-02-12
AU3697097A (en) 1998-02-25
CA2256751C (en) 2008-09-23
EP0942718B1 (fr) 2005-07-27
FR2752162A1 (fr) 1998-02-13
DZ2272A1 (fr) 2004-06-20
ES2130081A1 (es) 1999-06-16
ITGE970067A1 (it) 1999-02-06
KR20000029866A (ko) 2000-05-25
TR199900261T2 (xx) 1999-04-21
GR1002907B (el) 1998-05-13

Similar Documents

Publication Publication Date Title
MX9706053A (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
MY138227A (en) Valdecoxib compositions
MY118371A (en) Tetrahydrolipstatin containing compositions
AU1232600A (en) Dosage forms containing taste masked active agents
HK1050839A1 (en) Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state
AP1637A (en) Celecoxib compositions.
CY2459B1 (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole.
BG105857A (en) Pregelatinized starch in a controlled release formulation
BG103862A (en) Compositions of derivatives of erythromycin with continuous release
HUP0004966A2 (en) Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine
ATE243504T1 (de) Cefadroxilmonohydrat tablettenformulierung
IL148200A0 (en) Pharmaceutical compositions for oral and topical administration
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
IL136142A0 (en) High drug load immediate and modified release oral dosage formulations and processes for their manufacture
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
IL148777A (en) Mirtazepine oral oral administration unit
HUP0201667A2 (en) Oral form of administration
IL157539A0 (en) A stable pharmaceutical formulation comprising torsemide modification ii
MX2012004467A (es) Composiciones y metodos para la sedacion leve, ansiolisis y analgesia en el ambito de los procedimientos.